Wednesday, August 02, 2017 8:59:06 AM
I guess its a matter of perspective. The stock may be dead to you, but for myself, it is very much alive. I've recognized I am holding stock in a company that is building the worlds most advanced FAIMS device that ultimately will be hand-held and capable of detecting a rather large range of diseases through breath analysis. I'm "in" early, very early. The advantage of this is that I have bought my stock at an incredibly low price. It is not a 3 month hold and flip scenario. Stock price will increase in measured amounts as the device gets closer to market. Ask your "future self" if it was worth buying breathtec at $0.085 cents, 48 months ago when the stock is now surpassing the $5.00 dollar mark...Wait for the clinical trials to start and finish. Wait for the prototypes to develop through the various stages. Wait for the device to be completed and hit the market. Can you imagine what a buying frenzy will occur at that time? Classic example of "Delayed Gratification". Stay strong and "Hold" what you have. If you can. It will be worth it$
STC
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM